SVT-40776 25mg 25mg | Purity Not Available
Adooq Bioscience
SVT-40776 is a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
More Information Supplier PageSVT-40776 is a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
More Information Supplier PageSVT-40776 is a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
More Information Supplier PageSVT-40776 is a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
More Information Supplier PageRosiglitazone works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin.
More Information Supplier PageRosiglitazone works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin.
More Information Supplier PageRosiglitazone works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin.
More Information Supplier PageRosiglitazone works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin.
More Information Supplier PageRosiglitazone works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin.
More Information Supplier PageRoscovitine (Seliciclib) is a CDK inhibitor that preferentially inhibit multiple enzyme targets including CDK2, CDK7 and CDK9.
More Information Supplier PageRO4929097 is an orally bioavailable, small-molecule gamma secretase (GS) inhibitor with an IC50 of 4 nM.
More Information Supplier Page